These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21712824)

  • 1. Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.
    Jeyapalan JN; Noor DA; Lee SH; Tan CL; Appleby VA; Kilday JP; Palmer RD; Schwalbe EC; Clifford SC; Walker DA; Murray MJ; Coleman N; Nicholson JC; Scotting PJ
    Br J Cancer; 2011 Aug; 105(4):575-85. PubMed ID: 21712824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression.
    Murray MJ; Saini HK; van Dongen S; Palmer RD; Muralidhar B; Pett MR; Piipari M; Thornton CM; Nicholson JC; Enright AJ; Coleman N
    Mol Cancer; 2010 Nov; 9():290. PubMed ID: 21059207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group.
    Williams LA; Mills L; Hooten AJ; Langer E; Roesler M; Frazier AL; Krailo M; Nelson HH; Bestrashniy J; Amatruda JF; Poynter JN
    Br J Cancer; 2018 Oct; 119(7):864-872. PubMed ID: 30287918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets.
    Kubota Y; Seki M; Kawai T; Isobe T; Yoshida M; Sekiguchi M; Kimura S; Watanabe K; Sato-Otsubo A; Yoshida K; Suzuki H; Kataoka K; Fujii Y; Shiraishi Y; Chiba K; Tanaka H; Hiwatari M; Oka A; Hayashi Y; Miyano S; Ogawa S; Hata K; Tanaka Y; Takita J
    Commun Biol; 2020 Sep; 3(1):544. PubMed ID: 32999426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
    Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
    J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants.
    Kato N; Shibuya H; Fukase M; Tamura G; Motoyama T
    Hum Pathol; 2006 Jan; 37(1):48-53. PubMed ID: 16360415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
    Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
    Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors.
    Amatruda JF; Ross JA; Christensen B; Fustino NJ; Chen KS; Hooten AJ; Nelson H; Kuriger JK; Rakheja D; Frazier AL; Poynter JN
    BMC Cancer; 2013 Jun; 13():313. PubMed ID: 23806198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
    Roll JD; Rivenbark AG; Jones WD; Coleman WB
    Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric malignant germ cell tumors show characteristic transcriptome profiles.
    Palmer RD; Barbosa-Morais NL; Gooding EL; Muralidhar B; Thornton CM; Pett MR; Roberts I; Schneider DT; Thorne N; Tavaré S; Nicholson JC; Coleman N;
    Cancer Res; 2008 Jun; 68(11):4239-47. PubMed ID: 18519683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
    Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
    J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology.
    Poynter JN; Bestrashniy JR; Silverstein KA; Hooten AJ; Lees C; Ross JA; Tolar J
    BMC Cancer; 2015 Oct; 15():769. PubMed ID: 26497383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1).
    Lind GE; Skotheim RI; Fraga MF; Abeler VM; Esteller M; Lothe RA
    J Pathol; 2006 Dec; 210(4):441-9. PubMed ID: 17029216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells.
    Zhang Y; Chen FQ; Sun YH; Zhou SY; Li TY; Chen R
    J Exp Clin Cancer Res; 2011 Oct; 30(1):98. PubMed ID: 21999220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methyltransferase-3 like protein expression in various histological types of testicular germ cell tumor.
    Matsuoka T; Kawai K; Ando S; Sugita S; Kandori S; Kojima T; Miyazaki J; Nishiyama H
    Jpn J Clin Oncol; 2016 May; 46(5):475-81. PubMed ID: 26917601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
    Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
    Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants.
    Kato N; Tamura G; Fukase M; Shibuya H; Motoyama T
    Am J Pathol; 2003 Aug; 163(2):387-91. PubMed ID: 12875960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
    Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput microRNAome analysis in human germ cell tumours.
    Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
    J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.